SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-194114
Filing Date
2021-06-21
Accepted
2021-06-21 07:00:56
Documents
14
Period of Report
2021-06-19
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d169538d8k.htm   iXBRL 8-K 23823
2 EX-99.1 d169538dex991.htm EX-99.1 8537
6 GRAPHIC g169538g15c10.jpg GRAPHIC 7503
  Complete submission text file 0001193125-21-194114.txt   176845

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bhc-20210619.xsd EX-101.SCH 2733
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20210619_lab.xml EX-101.LAB 19579
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20210619_pre.xml EX-101.PRE 12276
7 EXTRACTED XBRL INSTANCE DOCUMENT d169538d8k_htm.xml XML 3961
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 211027337
SIC: 2834 Pharmaceutical Preparations